Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Record History now includes a new Study Status entry on 2025-12-30. The total number of Study Record Versions is updated to 11 on 2025-12-23, and a deletion occurred on 2025-10-01.
    Difference
    0.4%
    Check dated 2025-12-30T23:52:59.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Footer area now displays Revision: v3.3.3 and no longer shows HHS Vulnerability Disclosure or Revision: v3.3.2. This is a minor site maintenance change and does not affect the study record content.
    Difference
    0.2%
    Check dated 2025-12-23T22:37:27.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    A new Revision: v3.3.2 was added to the Record History and the previous Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:42.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Deleted a notice about a lapse in government funding and potential processing delays, including references to cc.nih.gov and opm.gov for operating updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T07:22:16.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The two screenshots show the same version history entries with no substantive updates to study data or status; any difference appears cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:26:20.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Major update to operating-status notice and versioning (v3.2.0) with a new date window; older status and revision were removed.
    Difference
    14%
    Check dated 2025-10-06T07:52:47.000Z thumbnail image

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.